Immunogenicity of Protein Therapeutics: Risk Assessment and Risk Mitigation

作者: Harald Kropshofer

DOI: 10.1002/9783527674183.CH15

关键词: Risk managementIn vitroImmunologyCd4 t cellProtein therapeuticsBiologyImmunogenicityRisk assessment

摘要:

参考文章(67)
Petra AM Warmerdam, Stéphane Plaisance, Kristel Vanderlick, Petra Vandervoort, Kathleen Brepoels, Désiré Collen, Marc De Maeyer, None, Elimination of a human T-cell region in staphylokinase by T-cell screening and computer modeling. Thrombosis and Haemostasis. ,vol. 87, pp. 666- 673 ,(2002) , 10.1055/S-0037-1613064
X Zhang, L J Wysocki, M C Eyerman, T cell recognition and tolerance of antibody diversity. Journal of Immunology. ,vol. 157, pp. 1037- 1046 ,(1996)
Kathleen P. Pratt, Arthur R. Thompson, B-Cell and T-Cell Epitopes in Anti-factor VIII Immune Responses Clinical Reviews in Allergy & Immunology. ,vol. 37, pp. 80- 95 ,(2009) , 10.1007/S12016-009-8120-7
Anne S. De Groot, Andrew Bosma, Natasha Chinai, Julie Frost, Bill M. Jesdale, Michael A. Gonzalez, William Martin, Caitlin Saint-Aubin, From genome to vaccine: in silico predictions, ex vivo verification. Vaccine. ,vol. 19, pp. 4385- 4395 ,(2001) , 10.1016/S0264-410X(01)00145-1
Gopi Shankar, Viswanath Devanarayan, Lakshmi Amaravadi, Yu Chen Barrett, Ronald Bowsher, Deborah Finco-Kent, Michele Fiscella, Boris Gorovits, Susan Kirschner, Michael Moxness, Thomas Parish, Valerie Quarmby, Holly Smith, Wendell Smith, Linda A. Zuckerman, Eugen Koren, Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products Journal of Pharmaceutical and Biomedical Analysis. ,vol. 48, pp. 1267- 1281 ,(2008) , 10.1016/J.JPBA.2008.09.020
Gary Walsh, Biopharmaceutical benchmarks 2010 Nature Biotechnology. ,vol. 28, pp. 917- 924 ,(2010) , 10.1038/NBT0910-917
Trevor T. Hansel, Harald Kropshofer, Thomas Singer, Jane A. Mitchell, Andrew J. T. George, The safety and side effects of monoclonal antibodies Nature Reviews Drug Discovery. ,vol. 9, pp. 325- 338 ,(2010) , 10.1038/NRD3003
Leonard Moise, Chang Song, William D. Martin, Ryan Tassone, Anne S. De Groot, David W. Scott, Effect of HLA DR epitope de-immunization of Factor VIII in vitro and in vivo Clinical Immunology. ,vol. 142, pp. 320- 331 ,(2012) , 10.1016/J.CLIM.2011.11.010
Maria D.F.S. Barbosa, Jost Vielmetter, Seung Chu, David D. Smith, Jonathan Jacinto, Clinical link between MHC class II haplotype and interferon-beta (IFN-β) immunogenicity Clinical Immunology. ,vol. 118, pp. 42- 50 ,(2006) , 10.1016/J.CLIM.2005.08.017
M. Congia, S. Patel, A. P. Cope, S. De Virgiliis, G. Sonderstrup, T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin Proceedings of the National Academy of Sciences of the United States of America. ,vol. 95, pp. 3833- 3838 ,(1998) , 10.1073/PNAS.95.7.3833